Currently out of the existing stock ratings of James Sidoti, 14 are a BUY (77.78%), 4 are a HOLD (22.22%).

James Sidoti

Work Performance Price Targets & Ratings Chart

Analyst James Sidoti, currently employed at SIDOTI, carries an average stock price target met ratio of 51.39% that have a potential upside of 17.08% achieved within 76 days.

James Sidoti’s has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ANIK, Anika Therapeutics at 09-Aug-2023.

Wall Street Analyst James Sidoti

Analyst best performing recommendations are on CUTR (CUTERA).
The best stock recommendation documented was for CUTR (CUTERA) at 7/6/2017. The price target of $32 was fulfilled within 33 days with a profit of $5.65 (21.44%) receiving and performance score of 6.5.

Average potential price target upside

CODX Co-Diagnostics LMAT LeMaitre Vascular STAA STAAR Surgical Company VREX Varex Imaging Corp CUTR Cutera ANIK Anika Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.5

$0.49 (48.51%)

$1.5

1 months 10 days ago
(11-Nov-2024)

3/20 (15%)

$0.32 (27.12%)

25

Hold

$3

$1.99 (197.03%)

$2

1 years 1 months 8 days ago
(13-Nov-2023)

1/5 (20%)

$1.85 (160.87%)

318

Hold

$5

$3.99 (395.05%)

$14

2 years 4 months 9 days ago
(12-Aug-2022)

0/2 (0%)

$0.52 (11.61%)

Buy

$30

3 years 8 months 23 days ago
(29-Mar-2021)

1/1 (100%)

$11.42 (61.46%)

75

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by James Sidoti?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?